References
Buonagurio DA, Bechert TM, Yang CF, et. al. Genetic stability of live, cold-adapted influenza virus components of the FluMist/CAIV-T vaccine throughout the manufacturing process. Vaccine. 2005 Nov 21; [Epub ahead of print] .
Harper SA, Fukuda K, Uyeki TM, Cox NJ, Bridges CB; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2005 Jul 29;54(RR-8):1-40. Erratum in: MMWR Morb Mortal Wkly Rep. 2005 Aug 5;54(30):750.
US Food and Drug Administration. FDA Approves Nasal Influenza Vaccine for Use in Younger Children. Rockville, MD: National Press Office; September 19, 2007.
Print
